Healthcare
Discover news, funding updates, regulatory changes, and sector insights impacting the health care industry in India.
Healthcare
Torrent Pharma to acquire Unichem's India biz for $558 mn
Ahmedabad-based drugmaker Torrent Pharmaceuticals Ltd has agreed to acquire the branded formulations business of Unichem Laboratories Ltd in India and ......
Healthcare
How can healthcare companies balance costs, pricing and quality?
In recent months, the government has imposed price controls on coronary stents, orthopedic implants and several drugs. On the other ......
Healthcare
Alembic acquires US generic drug developer Orit Laboratories
Alembic Pharmaceuticals Ltd said on Wednesday it has bought US-based generic drug developer Orit Laboratories LLC from Okner Realty LLC ......
Healthcare
TA Associates scores exit from healthcare portfolio firm
US-based private equity firm TA Associates has sold its entire stake in a healthcare portfolio firm with healthy returns, its ......
Healthcare
Aurobindo Pharma ends big-ticket bid for Mallinckrodt's generics biz
Drugmaker Aurobindo Pharma Ltd has walked away from the race to purchase the generics business of UK-based Mallinckrodt Plc in ......
Healthcare
Regency Healthcare's Abhishek Kapoor on unique IPO in 1990s, dreams to list again
Kanpur-based Regency Healthcare Ltd was publicly listed before it got private equity funding from International Finance Corp, Healthquad and KOIS ......
Healthcare
Company Watch: Tata Capital-backed Sai Life Sciences seeks to cram in growth
At a time when most Indian pharmaceutical companies were having a tough time due to challenges from both domestic and ......
Healthcare
True North expanding investment mandate to pharma, technology
Private equity firm True North has invested 30% of its fifth fund, bulk of which has been deployed, in healthcare ......
Healthcare
S-Squared Capital to inject fresh money into Vatsalya Dental
US-based S-Squared Capital Investments has committed to invest another Rs 20 crore ($3.06 million) in Special Smiles Pvt Ltd, which ......
Healthcare
Lupin buys US-based Symbiomix Therapeutics for $150 mn
Homegrown drugmaker Lupin Ltd has acquired US-based Symbiomix Therapeutics LLC for a cash consideration of $150 million (Rs 980 crore) ......
Most Popular
Google News
Follow VCCircle on Google News for the latest updates on Business and Startup News